Lack of dehydroepiandrosterone effect on a combined endurance and resistance exercise program in postmenopausal women
- PMID: 18029465
- PMCID: PMC2729150
- DOI: 10.1210/jc.2007-1027
Lack of dehydroepiandrosterone effect on a combined endurance and resistance exercise program in postmenopausal women
Abstract
Context: Recent studies disputed the widely promoted anti-aging effect of dehydroepiandrosterone (DHEA) supplementation; however, conflicting data exist on whether physiological DHEA supplementation enhances exercise training effects on body composition, physical performance, and cardiometabolic risk in healthy postmenopausal women.
Objective: The aim of this study was to determine whether 12 wk of DHEA supplementation (50 mg/d) in postmenopausal women enhances exercise-related changes in body composition, physical performance, and cardiometabolic risk.
Design and setting: This study was a 12-wk randomized double-blind, placebo-controlled trial and took place at the Mayo Clinic General Clinical Research Center (Rochester, MN).
Participants: Thirty-one sedentary, postmenopausal, Caucasian women (mean +/- sem age 64.6 +/- 1.0 yr) completed the study.
Intervention: Participants were randomized to one of two 12-wk interventions: 1) exercise training plus 50 mg/d of DHEA (n = 17), or 2) exercise training plus placebo (n = 14). The exercise intervention consisted of both endurance (4 d/wk) and resistance (3 d/wk) exercise components.
Main outcome measures: The main outcomes were measures of body composition, physical performance, and measures of cardiometabolic risk.
Results: DHEA treatment with exercise resulted in increases in circulating sulfated DHEA (650%), total testosterone (100%), estradiol (165%), estrone (85%), and IGF-I (30%) (all P < or = 0.05, for all within and between treatment comparisons). Although exercise training alone significantly improved physical performance, body composition, and insulin sensitivity, administration of DHEA provided no additional benefits.
Conclusions: Twelve weeks of combined endurance and resistance training significantly improved body composition, physical performance, insulin sensitivity, and low-density lipoprotein cholesterol particle number and size, whereas DHEA had no additional benefits.
Similar articles
-
The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women.Clin Endocrinol (Oxf). 1998 Oct;49(4):421-32. doi: 10.1046/j.1365-2265.1998.00507.x. Clin Endocrinol (Oxf). 1998. PMID: 9876338 Clinical Trial.
-
Postmenopausal dehydroepiandrosterone administration increases free insulin-like growth factor-I and decreases high-density lipoprotein: a six-month trial.Fertil Steril. 1998 Jul;70(1):107-10. doi: 10.1016/s0015-0282(98)00121-6. Fertil Steril. 1998. PMID: 9660430 Clinical Trial.
-
Oral dehydroepiandrosterone supplementation modulates spontaneous and growth hormone-releasing hormone-induced growth hormone and insulin-like growth factor-1 secretion in early and late postmenopausal women.Fertil Steril. 2001 Aug;76(2):241-8. doi: 10.1016/s0015-0282(01)01902-1. Fertil Steril. 2001. PMID: 11476767
-
Dehydroepiandrosterone on metabolism and the cardiovascular system in the postmenopausal period.J Mol Med (Berl). 2020 Jan;98(1):39-57. doi: 10.1007/s00109-019-01842-5. Epub 2019 Nov 12. J Mol Med (Berl). 2020. PMID: 31713639 Review.
-
Clinical review: The benefits and harms of systemic dehydroepiandrosterone (DHEA) in postmenopausal women with normal adrenal function: a systematic review and meta-analysis.J Clin Endocrinol Metab. 2014 Oct;99(10):3536-42. doi: 10.1210/jc.2014-2261. J Clin Endocrinol Metab. 2014. PMID: 25279571 Free PMC article. Review.
Cited by
-
Performance-Enhancing Drugs in Healthy Athletes: An Umbrella Review of Systematic Reviews and Meta-analyses.Sports Health. 2024 Sep-Oct;16(5):695-705. doi: 10.1177/19417381231197389. Epub 2023 Sep 9. Sports Health. 2024. PMID: 37688400 Free PMC article.
-
Hormones and Aging: An Endocrine Society Scientific Statement.J Clin Endocrinol Metab. 2023 Jul 14;108(8):1835-1874. doi: 10.1210/clinem/dgad225. J Clin Endocrinol Metab. 2023. PMID: 37326526 Free PMC article.
-
Cardiovascular phenotype of long-term anabolic-androgenic steroid abusers compared with strength-trained athletes.Scand J Med Sci Sports. 2022 Aug;32(8):1170-1181. doi: 10.1111/sms.14172. Epub 2022 May 4. Scand J Med Sci Sports. 2022. PMID: 35460300 Free PMC article.
-
The Therapeutic Intervention of Sex Steroid Hormones for Sarcopenia.Front Med (Lausanne). 2021 Oct 25;8:739251. doi: 10.3389/fmed.2021.739251. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34760899 Free PMC article. Review.
-
Linking Physical Activity to Breast Cancer via Sex Hormones, Part 1: The Effect of Physical Activity on Sex Steroid Hormones.Cancer Epidemiol Biomarkers Prev. 2022 Jan;31(1):16-27. doi: 10.1158/1055-9965.EPI-21-0437. Epub 2021 Oct 20. Cancer Epidemiol Biomarkers Prev. 2022. PMID: 34670800 Free PMC article. Review.
References
-
- Orentreich N, Brind JL, Rizer RL, Vogelman JH 1984 Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 59:551–555 - PubMed
-
- Barrett-Connor E, Khaw K-T, Yen SSC 1986 A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. N Engl J Med 315:1519–1524 - PubMed
-
- Dhatariya KK, Nair KS 2003 Dehydroepiandrosterone: is there a role for replacement? Mayo Clin Proc 78:1257–1273 - PubMed
-
- Tchernof A, Labrie F 2004 Dehydroepiandrosterone, obesity and cardiovascular disease risk: a review of human studies. Eur J Endocrinol 151:1–14 - PubMed
-
- Karakelides H, Sreekumaran Nair K 2005 Sarcopenia of aging and its metabolic impact. Curr Top Dev Biol 68:123–148 - PubMed
